COLUMBIA, S.C., April 24, 2013 /PRNewswire/ -- HarborPath, an organization which provides a single point of access to HIV/AIDS medications through patient assistance programs, welcomes Gilead Sciences as a participating company. Gilead joins Merck and ViiV Healthcare as the third pharmaceutical company to support HarborPath since its launch in July 2012.
"With Gilead's support of this pilot program, we can extend the reach of the organization and offer access to a broader-range of HIV/AIDS medications," said Ken Trogdon, Jr. , President of HarborPath. "We are thankful for the support of our pharmaceutical company partners and we urge others to join our efforts to serve individuals who need access to medications through patient assistance programs. These programs are a safety net for those who cannot afford their medications and they provide access to the life-saving drugs that allow people living with HIV/AIDS to live longer and healthier lives."
HarborPath is currently piloting the program in six states and Washington, D.C., having most recently added a clinic in South Carolina. HarborPath provides a streamlined process for healthcare professionals and case managers to connect individuals living with HIV/AIDS to multiple patient assistance programs using the common application form on the HarborPath website. The donated medications are delivered at no cost to qualified individuals through HarborPath's contracted mail-order pharmacy.
"Access to medicines should never be a barrier to care, and I'm encouraged by HarborPath's efforts to ensure streamlined access to life-saving medications for people living with HIV/AIDS," said Congresswoman Barbara Lee of California, Co-Chair of the Congressional HIV/AIDS Caucus. "All stakeholders, including the government, private sector, faith communities, and the philanthropic community have an important role to play to ensure HIV/AIDS medications reach those who need them."
HarborPath is a 501(c) (3) organization whose mission is to provide streamlined access to HIV/AIDS medications through patient assistance programs via an online portal. For more information, visit www.harborpath.org.
Copyright©2012 PR Newswire.
All rights reserved